Remote Project

  • Research type

    Research Study

  • Full title

    An individualised 8-week remote exercise intervention to improve Quality of Life, Cardiometabolic risk and physical activity level in men with prostate cancer undergoing ADT treatment.

  • IRAS ID

    331866

  • Contact name

    Ralph JF Manders

  • Contact email

    ralph.manders@NHS.net

  • Sponsor organisation

    University of Surrey

  • Clinicaltrials.gov Identifier

    NCT05989854

  • Clinicaltrials.gov Identifier

    956732-956714-101614486, UoS SAGE

  • Duration of Study in the UK

    0 years, 11 months, 29 days

  • Research summary

    Currently, there are few opportunities for patients with cancer to have individual exercise guidance, and this has further been impacted by the Covid-19 pandemic. However, during the pandemic the use of virtual/remote platforms has been crucial in delivering care to cancer patients. We think that remote exercise training may also offer a solution to support positive change in prostate cancer patients. As a result, we have developed a remote/online exercise programme to explore this further.
    This study will explore the effectiveness of an 8-week remote exercise and behavioural support intervention, and whether prostate cancer patients feel they benefit from this. The study also aims to see if this sort of exercise programme can be delivered to more prostate cancer patients in the future. This project is open to men with prostate cancer on long term hormone therapy. The intervention will be comprised of one remote supervised session per week, completed 1-1 using an online platform and up to two additional sessions, depending on its suitability for the patient, will be prescribed as unsupervised home-based exercise.

  • REC name

    North East - Newcastle & North Tyneside 2 Research Ethics Committee

  • REC reference

    23/NE/0209

  • Date of REC Opinion

    9 Nov 2023

  • REC opinion

    Favourable Opinion